PubRank

S N Lehrman

Author PubWeight™ 41.24‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proc Natl Acad Sci U S A 1985 10.71
2 Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci U S A 1986 8.48
3 Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex. Lancet 1986 5.05
4 Suppression of frequently recurring genital herpes. A placebo-controlled double-blind trial of oral acyclovir. N Engl J Med 1984 2.26
5 3'-Azido-3'-deoxythymidine in feline leukemia virus-infected cats: a model for therapy and prophylaxis of AIDS. Cancer Res 1987 1.67
6 Enteroviruses and meningitis. Pediatr Infect Dis 1983 1.31
7 Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity. Antimicrob Agents Chemother 1987 1.24
8 Plaque autoradiography assay for the detection and quantitation of thymidine kinase-deficient and thymidine kinase-altered mutants of herpes simplex virus in clinical isolates. Antimicrob Agents Chemother 1985 1.17
9 Carbamazepine overdose. Am J Dis Child 1981 1.15
10 Recurrent genital herpes and suppressive oral acyclovir therapy. Relation between clinical outcome and in-vitro drug sensitivity. Ann Intern Med 1986 1.09
11 Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. Pediatric Zidovudine Phase I Study Group. J Pediatr 1990 0.98
12 Herpes simplex encephalitis in a patient with lymphoma. Relapse following acyclovir therapy. JAMA 1988 0.94
13 Progressive mucocutaneous herpes simplex infection due to acyclovir-resistant virus in an immunocompromised patient: correlation of viral susceptibilities and plasma levels with response to therapy. Diagn Microbiol Infect Dis 1987 0.90
14 Acyclovir suppression of frequently recurring genital herpes. Efficacy and diminishing need during successive years of treatment. JAMA 1988 0.87
15 Treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex with a regimen of 3'-azido-2',3'-dideoxythymidine (azidothymidine or zidovudine) and acyclovir. A pilot study. Ann Intern Med 1988 0.87
16 Extended acyclovir therapy for herpes genitalis: changes in virus sensitivity and strain variation. J Antimicrob Chemother 1986 0.85
17 Clinical and laboratory experience with acyclovir-resistant herpes viruses. J Antimicrob Chemother 1986 0.77
18 Double-blind comparison of weekend and daily regimens of oral acyclovir for suppression of recurrent genital herpes. Antiviral Res 1986 0.77
19 Zidovudine improves psoriasis in human immunodeficiency virus-positive males. Arch Dermatol 1994 0.76
20 Clinical trial evaluates effectiveness of zidovudine. AORN J 1989 0.75
21 Retrovir trial. Ann Emerg Med 1989 0.75
22 Zidovudine overdosage. Ann Intern Med 1988 0.75
23 Prophylactically administered Retrovir in health care workers potentially exposed to the human immunodeficiency virus. J Infect Dis 1988 0.75